These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 23787720)

  • 21. Prognostic value of monocyte count in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial).
    Greene SJ; Harinstein ME; Vaduganathan M; Subačius H; Konstam MA; Zannad F; Maggioni AP; Swedberg K; Butler J; Gheorghiade M;
    Am J Cardiol; 2012 Dec; 110(11):1657-62. PubMed ID: 22917555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    O'Connor CM; Abraham WT; Albert NM; Clare R; Gattis Stough W; Gheorghiade M; Greenberg BH; Yancy CW; Young JB; Fonarow GC
    Am Heart J; 2008 Oct; 156(4):662-73. PubMed ID: 18926148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter prospective observational study on acute and chronic heart failure: one-year follow-up results of IN-HF (Italian Network on Heart Failure) outcome registry.
    Tavazzi L; Senni M; Metra M; Gorini M; Cacciatore G; Chinaglia A; Di Lenarda A; Mortara A; Oliva F; Maggioni AP;
    Circ Heart Fail; 2013 May; 6(3):473-81. PubMed ID: 23476054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program.
    O'Connor CM; Miller AB; Blair JE; Konstam MA; Wedge P; Bahit MC; Carson P; Haass M; Hauptman PJ; Metra M; Oren RM; Patten R; Piña I; Roth S; Sackner-Bernstein JD; Traver B; Cook T; Gheorghiade M;
    Am Heart J; 2010 May; 159(5):841-849.e1. PubMed ID: 20435194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of morbidity in women versus men with heart failure and preserved ejection fraction.
    Deswal A; Bozkurt B
    Am J Cardiol; 2006 Apr; 97(8):1228-31. PubMed ID: 16616031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction.
    Hernandez AF; Mi X; Hammill BG; Hammill SC; Heidenreich PA; Masoudi FA; Qualls LG; Peterson ED; Fonarow GC; Curtis LH
    JAMA; 2012 Nov; 308(20):2097-107. PubMed ID: 23188026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of longitudinal measures of hemoglobin and outcomes after hospitalization for heart failure.
    Peterson PN; Magid DJ; Lyons EE; Clarke CL; Zeng C; Fitzgerald A; Lindenfeld J; Kosiborod M; Brand D; Masoudi FA
    Am Heart J; 2010 Jan; 159(1):81-9. PubMed ID: 20102871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low prealbumin is strongly associated with adverse outcome in heart failure.
    Lourenço P; Silva S; Friões F; Alvelos M; Amorim M; Couto M; Torres-Ramalho P; Guimarães JT; Araújo JP; Bettencourt P
    Heart; 2014 Nov; 100(22):1780-5. PubMed ID: 24986895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperuricemia in acute heart failure. More than a simple spectator?
    Alimonda AL; Núñez J; Núñez E; Husser O; Sanchis J; Bodí V; Miñana G; Robles R; Mainar L; Merlos P; Darmofal H; Llácer A
    Eur J Intern Med; 2009 Jan; 20(1):74-9. PubMed ID: 19237097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis(†): Meta-Analysis Global Group in Chronic heart failure (MAGGIC).
    Rusinaru D; Tribouilloy C; Berry C; Richards AM; Whalley GA; Earle N; Poppe KK; Guazzi M; Macin SM; Komajda M; Doughty RN;
    Eur J Heart Fail; 2012 Oct; 14(10):1139-46. PubMed ID: 22782968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of aldosterone and cortisol in patients hospitalized for acutely decompensated chronic heart failure with and without mineralocorticoid receptor antagonism.
    Güder G; Hammer F; Deutschbein T; Brenner S; Berliner D; Deubner N; Bidlingmaier M; Ertl G; Allolio B; Angermann CE; Fassnacht M; Störk S
    J Card Fail; 2015 Mar; 21(3):208-16. PubMed ID: 25573831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure.
    Güder G; Bauersachs J; Frantz S; Weismann D; Allolio B; Ertl G; Angermann CE; Störk S
    Circulation; 2007 Apr; 115(13):1754-61. PubMed ID: 17372171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure.
    Vaduganathan M; Marti CN; Mentz RJ; Greene SJ; Ambrosy AP; Subacius HP; Fonarow GC; Chioncel O; Bazari H; Maggioni AP; Zannad F; Konstam MA; Sato N; Gheorghiade M; Butler J;
    Am J Cardiol; 2016 Apr; 117(7):1144-50. PubMed ID: 26851146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.
    Bavishi C; Ather S; Bambhroliya A; Jneid H; Virani SS; Bozkurt B; Deswal A
    Am J Cardiol; 2014 Jun; 113(11):1834-8. PubMed ID: 24837261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee.
    Butler J; Ezekowitz JA; Collins SP; Givertz MM; Teerlink JR; Walsh MN; Albert NM; Westlake Canary CA; Carson PE; Colvin-Adams M; Fang JC; Hernandez AF; Hershberger RE; Katz SD; Rogers JG; Spertus JA; Stevenson WG; Sweitzer NK; Tang WH; Stough WG; Starling RC
    J Card Fail; 2012 Apr; 18(4):265-81. PubMed ID: 22464767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute heart failure patient profiles, management and in-hospital outcome: results of the Italian Registry on Heart Failure Outcome.
    Oliva F; Mortara A; Cacciatore G; Chinaglia A; Di Lenarda A; Gorini M; Metra M; Senni M; Maggioni AP; Tavazzi L;
    Eur J Heart Fail; 2012 Nov; 14(11):1208-17. PubMed ID: 22833614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of heart failure with preserved ejection fraction in a Southeast Asian cohort.
    Hoong CW; Lim CP; Gao F; Chen Q; Kawa LB; Ching CK; Sim DK
    J Cardiovasc Med (Hagerstown); 2015 Sep; 16(9):583-90. PubMed ID: 25022929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of in-hospital hyperglycemia in hospitalized patients with acute heart failure: Results of the IN-HF (Italian Network on Heart Failure) Outcome registry.
    Targher G; Dauriz M; Tavazzi L; Temporelli PL; Lucci D; Urso R; Lecchi G; Bellanti G; Merlo M; Rossi A; Maggioni AP;
    Int J Cardiol; 2016 Jan; 203():587-93. PubMed ID: 26574932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional mitral regurgitation at discharge and outcomes in patients hospitalized for acute decompensated heart failure with a preserved or reduced ejection fraction.
    Kajimoto K; Sato N; Takano T;
    Eur J Heart Fail; 2016 Aug; 18(8):1051-9. PubMed ID: 27212582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure.
    Solomon SD; Dobson J; Pocock S; Skali H; McMurray JJ; Granger CB; Yusuf S; Swedberg K; Young JB; Michelson EL; Pfeffer MA;
    Circulation; 2007 Sep; 116(13):1482-7. PubMed ID: 17724259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.